This paper reports on treatments with three anticancer drugs (Carzinophilin, Toyomycin and Endoxan), performed on patients with head and neck malignancies.
The treated patients numbered 22 cases (8 cases of maxillary cancer, 6 cases of laryngeal cancer, 3 cases of lingual cancer, 2 cases of epipharyngeal sarcoma and 3 cases in other regions), and administration of the drugs was made intravenously in almost all cases.
A few patients (4 cases) were treated with anticancer drug only, but majority were given it in combination with radiotherapy and/or radical operation.
The efficacy was objectively visible in 1 of 4 cases treated with carzinophilin, in 2 of 7 cases treated with Toyomycin. Of 11 cases given Endoxan, 1 case of relapsing laryngeal cancer showed reduction in tumor size, and 6 cases who were given Endoxan after operation did not show relapse during a period from 5 months to 1 year and 2 months observation.
It was of interest that all these cases of favorable response did not receive the anticancer drug alone, but received it in combination with rodiotherapy with or without operation.
As for side effect on the hemopoietic organ, Carzinophilin produced it in 75%, Toyomycin in 0%, and Endoxan in 27%.
抄録全体を表示